4.7 Article

Smad6 Suppresses the Growth and Self-Renewal of Hepatic Progenitor Cells

Journal

JOURNAL OF CELLULAR PHYSIOLOGY
Volume 229, Issue 5, Pages 651-660

Publisher

WILEY
DOI: 10.1002/jcp.24488

Keywords

-

Funding

  1. National Natural Science Foundation of China [30973498, 81072001]
  2. State Key Project on Infection Disease of China [2012ZX10002016-004, 2012ZX10002010-001-004]
  3. Chinese Ministry of Public Health for Key Clinical Project [[2010] 493-51]
  4. Graduate Practice Base of Innovation and Enterprise, Huazhong University of Science and Technology [HF-09-34-2011-540, 2011JC065]

Ask authors/readers for more resources

Activation of hepatic progenitor cells (HPCs) is commonly observed in chronic liver disease and Wnt/-catenin signaling plays a crucial role in the expansion of HPCs. However, the molecular mechanisms that regulate the activation of Wnt/-catenin signaling in the liver, especially in HPCs, remain largely elusive. Here, we reported that ectopic expression of Smad6 suppressed the proliferation and self-renewal of WB-F344 cells, a HPC cell line. Mechanistically, we found that Smad6 inhibited Wnt/-catenin signaling through promoting the interaction of C-terminal binding protein (CtBP) with -catenin/T-cell factor (TCF) complex to inhibit -catenin mediated transcriptional activation in WB-F344 cells. We used siRNA targeting -catenin to demonstrate that Wnt/-catenin signaling was required for the proliferation and self-renewal of HPCs. Taken together, these results suggest that Smad6 is a regulatory molecule which regulates the proliferation, self-renewal and Wnt/-catenin signaling in HPCs. J. Cell. Physiol. 229: 651-660, 2014. (c) 2013 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cell Biology

Development and validation of a CpG island methylator phenotype-related prognostic signature for cholangiocarcinoma

Junnan Liang, Tongtong Liu, Jingyu Liao, Lu Zhang, Mi Zhou, Weiqi Xu, Yi He, Guangzhen Cai, Guannan Jin, Jia Song, Ganxun Li, Huifang Liang, Zeyang Ding, Bixiang Zhang

Summary: The study identified a CIMP-related methylation signature specific for CCA (CMSC) that can classify patients into different risk groups and predict patient outcomes. Additionally, a subset of patients with an unfavorable prognosis correlated with CIMP-H was identified. Gene enrichment analysis suggested a potential mechanism of CIMP as a promoter of carcinogenesis by regulating proliferation.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Chemistry, Multidisciplinary

Hyperbaric Oxygen Boosts PD-1 Antibody Delivery and T Cell Infiltration for Augmented Immune Responses Against Solid Tumors

Xin Liu, Ningbing Ye, Sha Liu, Jiankun Guan, Qingyuan Deng, Zhijie Zhang, Chen Xiao, Ze-yang Ding, Bi-xiang Zhang, Xiao-ping Chen, Zifu Li, Xiangliang Yang

Summary: This study utilized hyperbaric oxygen (HBO) to overcome mechanical and immunosuppressive limitations of T cell immune checkpoint inhibitors, such as PD-1 Ab, against solid tumors. HBO enhanced PD-1 Ab delivery and T cell infiltration, disrupting immunosuppression and promoting robust immune responses to inhibit tumor relapses. Such enhanced efficacy was observed in solid tumors in rodents and hepatocellular carcinoma patients, highlighting the potential of HBO-PD-1 Ab combination therapy in stroma-rich solid tumors.

ADVANCED SCIENCE (2021)

Article Oncology

Construction and Validation of a Nomogram for Predicting the Risk of Deep Vein Thrombosis in Hepatocellular Carcinoma Patients After Laparoscopic Hepatectomy: A Retrospective Study

Yao Chen, Jianping Zhao, Zhanguo Zhang, Zeyang Ding, Yifa Chen, Xiaoping Chen, Wanguang Zhang

Summary: This study developed a DVT risk prediction model (TRN) based on data from a large number of hepatocellular carcinoma patients who underwent laparoscopic hepatectomy, demonstrating good predictive value in both internal and external validation.

JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)

Article Biochemistry & Molecular Biology

Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation

Junnan Liang, Ganxun Li, Jingyu Liao, Zhao Huang, Jingyuan Wen, Yu Wang, Zeyu Chen, Guangzhen Cai, Weiqi Xu, Zeyang Ding, Huifang Liang, Pran K. Datta, Liang Chu, Xiaoping Chen, Bixiang Zhang

Summary: This study reveals the role of SNORD17 in hepatocellular carcinoma (HCC) and its interaction with p53, suggesting it as a potential therapeutic target for HCC.

CELL DEATH AND DIFFERENTIATION (2022)

Article Biochemistry & Molecular Biology

DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6

Xiaochao Zhang, Yabing Hu, Yonglong Pan, Yixiao Xiong, Yuxin Zhang, Mengzhen Han, Keshuai Dong, Jia Song, Huifang Liang, Zeyang Ding, Xuewu Zhang, He Zhu, Qiumeng Liu, Xun Lu, Yongdong Feng, Xiaoping Chen, Zhanguo Zhang, Bixiang Zhang

Summary: DDR1 is upregulated in hepatocellular carcinoma (HCC) tissues and high expression of DDR1 is associated with poor prognosis. DDR1 promotes HCC metastasis through collagen-induced signaling.

ONCOGENE (2022)

Article Oncology

Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway

Yonglong Pan, Mengzhen Han, Xiaochao Zhang, Yi He, Chaoyi Yuan, Yixiao Xiong, Xinxin Li, Chenglong Zeng, Kan Lu, He Zhu, Xun Lu, Qiumeng Liu, Huifang Liang, Zhibin Liao, Zeyang Ding, Zhanguo Zhang, Xiaoping Chen, Wanguang Zhang, Bixiang Zhang

Summary: The study reveals that DDR1 promotes liver cancer cell proliferation and tumor growth, while downregulation of DDR1 has the opposite effect. DDR1 interacts with SLC1A5 to regulate the mTORC1 signaling pathway. DDR1 serves as an independent prognostic marker, and its expression is positively correlated with SLC1A5 in clinical samples, providing new insights into HCC development and potential targets for treatment.

CELLULAR ONCOLOGY (2022)

Article Oncology

GRAMD4 inhibits tumour metastasis by recruiting the E3 ligase ITCH to target TAK1 for degradation in hepatocellular carcinoma

Qian Yun Ge, Jin Chen, Gan Xun Li, Xiao Long Tan, Jia Song, Deng Ning, Jie Mo, Peng Cheng Du, Qiu Meng Liu, Hui Fang Liang, Ze Yang Ding, Xue Wu Zhang, Bi Xiang Zhang

Summary: GRAMD4 inhibits the migration and metastasis of HCC by promoting the degradation of TAK1, which leads to the inactivation of MAPK and NF-kappa B signalling pathways.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

Article Immunology

A Novel hepatocellular carcinoma specific hypoxic related signature for predicting prognosis and therapeutic responses

Guangzhen Cai, Jinghan Zhu, Deng Ning, Ganxun Li, Yuxin Zhang, Yixiao Xiong, Junnan Liang, Chengpeng Yu, Xiaoping Chen, Huifang Liang, Zeyang Ding

Summary: The role of hypoxia in hepatocellular carcinoma and its impact on the tumor microenvironment and drug sensitivity are not well understood. This study found that the Hypoxia_DEGs_Score model has excellent predictive value for survival. Hypoxia is closely related to somatic mutation, copy number variation, and DNA methylation, which affect tumor development, metastasis, and drug resistance. Aggravated hypoxic stress leads to immune exclusion phenotype and increased infiltration of immunosuppressive cells. Patients with high Hypoxia_DEGs_Score have worse immunotherapeutic outcomes and prognosis, and may benefit from drugs targeting cell cycle signaling pathways rather than those inhibiting the PI3K/mTOR pathway. Hypoxia_DEGs_Score can predict changes in the tumor microenvironment, the efficacy of immunotherapy, and drug response.

FRONTIERS IN IMMUNOLOGY (2022)

Review Oncology

Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedside

Yiyang Liu, Yufei Wang, Sheng Sun, Zeyu Chen, Shuai Xiang, Zeyang Ding, Zhao Huang, Bixiang Zhang

Summary: This article investigates the role of EpCAM in cancer and its communication with other signaling pathways. It introduces the impact on the biology of cancers and the latest clinical applications of EpCAM, aiming to shed light on its translational prospects.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2022)

Article Chemistry, Multidisciplinary

Hydroxyethyl starch stabilized copper-diethyldithiocarbamate nanocrystals for cancer therapy

Chen Xiao, Jiayuan Li, Xing Wang, Shiyou Li, Chen Xu, Zhijie Zhang, Ao Hua, Ze-yang Ding, Bi-xiang Zhang, Xiangliang Yang, Zifu Li

Summary: Cancer stem cells (CSCs) are responsible for tumor progression, treatment resistance, metastasis, and recurrence, but few drugs have successfully eliminated CSCs by increasing oxidative stress. In this study, we introduced hydroxyethyl starch stabilized copper-diethyldithiocarbamate nanoparticles (CuET@HES NPs) that effectively suppressed CSCs in vitro and in various in vivo tumor models. The CuET@HES NPs also showed great efficacy in inhibiting CSCs in fresh tumor tissues from hepatocellular carcinoma patients. This research has significant implications for the development of CSC-targeting nanomedicines.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Urology & Nephrology

Tubular cell transcriptional intermediary factor 1y deficiency exacerbates kidney injury-induced tubular cell and fibrosis

Chaoyi Yuan, Guannan Jin, Pengcheng Li, Wei Wang, Chang Ge, Yonglong Pan, Qiaofeng Zhang, Jie Mo, Dong Kuang, Liu Liu, Xuewu Zhang, Huifang Liang, Wanguang Zhang, Xi Tang, Zifu Li, Jihong Liu, Gang Xu, Xiaoping Chen, Ze-yang Ding, Bixiang Zhang

Summary: Tubulointerstitial fibrosis is the final path of progressive chronic kidney diseases regardless of the cause. The transcriptional intermediary factor 1y (TIF1y) has been found to be highly expressed in the kidney tubules and inhibits the progression of fibrosis. Loss of TIF1y exacerbates tubular cell polyploidy and fibrosis, while overexpression protects against kidney fibrosis. TIF1y exerts its antifibrotic role by inhibiting TGF-D and EGFR signaling pathways.

KIDNEY INTERNATIONAL (2023)

Review Cell Biology

TRIM proteins in hepatocellular carcinoma

Kan Lu, Yonglong Pan, Zhao Huang, Huifang Liang, Ze-Yang Ding, Bixiang Zhang

Summary: The TRIM protein family is a versatile and highly conserved group of proteins that function as E3 ligases, regulating the development of hepatocellular carcinoma.

JOURNAL OF BIOMEDICAL SCIENCE (2022)

Review Medicine, Research & Experimental

Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy

Jitang Chen, Ze-yang Ding, Si Li, Sha Liu, Chen Xiao, Zifu Li, Bi-xiang Zhang, Xiao-ping Chen, Xiangliang Yang

Summary: Targeting TGF beta signaling for cancer therapy presents challenges and opportunities, as inhibitors can enhance chemotherapy efficacy but must also consider the dual role of TGF beta in normal tissues and tumors to avoid unwanted side effects.

THERANOSTICS (2021)

Article Medicine, Research & Experimental

The 14-3-3σ protein promotes HCC anoikis resistance by inhibiting EGFR degradation and thereby activating the EGFR-dependent ERK1/2 signaling pathway

Jia Song, Yachong Liu, Furong Liu, Lu Zhang, Ganxun Li, Chaoyi Yuan, Chengpeng Yu, Xun Lu, Qiumeng Liu, Xiaoping Chen, Huifang Liang, Zeyang Ding, Bixiang Zhang

Summary: The 14-3-3 sigma protein plays a pivotal role in anoikis resistance and metastasis of hepatocellular carcinoma cells by inhibiting EGFR degradation and regulating the activation of the EGFR-dependent ERK1/2 pathway. This study offers new research directions for targeting 14-3-3 sigma in the treatment of metastatic cancer.

THERANOSTICS (2021)

Article Oncology

Immunological Role and Prognostic Value of APBB1IP in Pan-Cancer Analysis

Qianyun Ge, Ganxun Li, Jin Chen, Jia Song, Guangzhen Cai, Yi He, Xuewu Zhang, Huifang Liang, Zeyang Ding, Bixiang Zhang

Summary: APBB1IP can serve as a prognostic biomarker in pan-cancer analysis. Upregulation of APBB1IP correlated with increased immune-cell infiltration, with its expression in different tumors possibly being related to the tumor immune microenvironment.

JOURNAL OF CANCER (2021)

No Data Available